Universal Health (UHS) Tops Q2 EPS by 22c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Leerink Partners Raises Price Target on Universal Health (UHS) Following 2Q EPS Beat
August 3, 2015 9:41 AM EDTLeerink Partners reiterated an Outperform rating on Universal Health Services (NYSE: UHS), and raises the price target to $165.00 (from $155.00), following 2Q results. 2Q EBITDA of $433MM and Adj. EPS at $1.85 beat consensus at $404MM and $1.63 respectively. 2015 EPS guidance was raised by 9% to $6.75-7.15 which implies the EBITDA guidance raise by ~$100MM to $1,700MM at mean.
Analyst Ana Gupte commented, "UHS posted a strong 2Q with top & bottom-line beats. Solid beat on Same... More
